CD274 and neoplasm: Recent studies have demonstrated that DSF has the ability to modulate the tumor immune microenvironment through manipulation of tumor-associated macrophages and regulation of PD-L1 expression, showing significant potential for synergistic immunotherapy in colorectal cancer.